Virus-Specific T Cells for the Immunocompromised Patient

While progress has been made in the treatment of both hematologic cancers and solid tumors, chemorefractory or relapsed disease often portends a dismal prognosis, and salvage chemotherapy or radiation expose patients to intolerable toxicities and may not be effective. Hematopoietic stem cell transpl...

Descripción completa

Detalles Bibliográficos
Autores principales: Houghtelin, Amy, Bollard, Catherine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641550/
https://www.ncbi.nlm.nih.gov/pubmed/29075259
http://dx.doi.org/10.3389/fimmu.2017.01272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641550/
https://www.ncbi.nlm.nih.gov/pubmed/29075259
http://dx.doi.org/10.3389/fimmu.2017.01272

Ejemplares similares